Management of Newborns with Maternal GBS Bacteremia

Risk Stratification and Initial Assessment

The Centers for Disease Control and Prevention recommends that any newborn born to a mother with GBS bacteremia requires immediate full diagnostic evaluation and empiric antibiotic therapy, regardless of the infant's clinical appearance, because maternal bacteremia represents active invasive infection rather than simple colonization 1, 2
Maternal bacteremia indicates active systemic infection, placing the newborn at substantially elevated risk for early-onset sepsis compared to simple maternal colonization 1
The newborn should be assessed immediately for any signs of sepsis including respiratory distress, temperature instability, poor feeding, lethargy, or hemodynamic instability 1, 2

Immediate full diagnostic evaluation is mandatory for any newborn with signs of sepsis, including blood culture, complete blood count with differential and platelet count, chest radiograph if any respiratory signs are present, and lumbar puncture if the infant is stable enough to tolerate the procedure and sepsis is suspected 1, 2
Empiric antibiotic therapy should be started immediately after obtaining cultures, with a combination of intravenous ampicillin and gentamicin to cover both GBS and other organisms such as E. coli 1, 2

The American College of Obstetricians and Gynecologists defines adequate intrapartum prophylaxis as ≥4 hours of penicillin, ampicillin, or cefazolin before delivery 2, 3
Even if the mother received adequate intrapartum prophylaxis, the presence of bacteremia indicates active invasive infection requiring more aggressive neonatal management 1

Empiric therapy should include ampicillin 100-200 mg/kg/day divided every 6-12 hours and gentamicin 3-5 mg/kg/day, with dosing intervals depending on gestational age 1, 2, 4
The duration of therapy depends on culture results and clinical course, with a minimum of 10 days for bacteremia without meningitis and 14-21 days for meningitis 2, 3, 4

All infants should be observed in hospital for a minimum of 48 hours with serial clinical assessments, and if discharged after negative cultures and clinical stability, ensure close outpatient follow-up within 24-48 hours 2, 3